Your browser doesn't support javascript.
loading
On-treatment biomarkers can improve prediction of response to neoadjuvant chemotherapy in breast cancer.
Bownes, Richard J; Turnbull, Arran K; Martinez-Perez, Carlos; Cameron, David A; Sims, Andrew H; Oikonomidou, Olga.
  • Bownes RJ; University of Edinburgh Cancer Research UK Centre, MRC Institute of Genetics and Molecular Medicine, Edinburgh, UK.
  • Turnbull AK; University of Edinburgh Cancer Research UK Centre, MRC Institute of Genetics and Molecular Medicine, Edinburgh, UK.
  • Martinez-Perez C; University of Edinburgh Cancer Research UK Centre, MRC Institute of Genetics and Molecular Medicine, Edinburgh, UK.
  • Cameron DA; University of Edinburgh Cancer Research UK Centre, MRC Institute of Genetics and Molecular Medicine, Edinburgh, UK.
  • Sims AH; Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK.
  • Oikonomidou O; University of Edinburgh Cancer Research UK Centre, MRC Institute of Genetics and Molecular Medicine, Edinburgh, UK. andrew.sims@ed.ac.uk.
Breast Cancer Res ; 21(1): 73, 2019 06 14.
Article en En | MEDLINE | ID: mdl-31200764
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores de Tumor Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores de Tumor Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Año: 2019 Tipo del documento: Article